No abstract available
MeSH terms
-
Adult
-
Aged
-
Aged, 80 and over
-
Androgen Antagonists / therapeutic use
-
Genetic Predisposition to Disease
-
Health Care Costs
-
Hospitalization
-
Humans
-
Incidence
-
Male
-
Mass Screening / economics
-
Mass Screening / methods
-
Middle Aged
-
Prognosis
-
Prostate-Specific Antigen / blood
-
Prostatic Neoplasms* / diagnosis
-
Prostatic Neoplasms* / economics
-
Prostatic Neoplasms* / mortality
-
Prostatic Neoplasms* / therapy
-
Referral and Consultation
-
Risk Factors
-
Workload
Substances
-
Androgen Antagonists
-
Prostate-Specific Antigen